Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Aug;86(2):137-42.
doi: 10.1532/IJH97.06173.

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation

Hideki Uchiumi  1 , Takafumi Matsushima, Arito Yamane, Noriko Doki, Hiroyuki Irisawa, Takayuki Saitoh, Tohru Sakura, Takahiro Jimbo, Hiroshi Handa, Norifumi Tsukamoto, Masamitsu Karasawa, Shuichi Miyawaki, Hirokazu Murakami, Yoshihisa Nojima
Affiliations

Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation

Hideki Uchiumi et al. Int J Hematol. 2007 Aug.

Abstract

Disseminated intravascular coagulation (DIC) is one of the important complications to develop in patients with acute myeloid leukemia (AML). While acute promyelocytic leukemia (APL) is a strong risk factor for DIC, other clinical features have not been fully defined. We retrospectively analyzed 161 consecutive adult patients with de novo non-APL AML. DIC was diagnosed in 52 patients (32%); 28 patients at diagnosis and 24 soon after the initiation of induction chemotherapy. Leukocyte counts, C-reactive protein, and lactate dehydrogenase were significantly higher in the DIC+ group. Negative expressions of CD13, CD19, CD34, and HLA-DR were more prevalent in the DIC+ group. On multivariate logistic-regression analysis, variables that were independently associated with the development of DIC were high C-reactive protein, high leukocyte count, negative expressions of CD13 and HLA-DR, and cytogenetics with a normal karyotype or 11q23 abnormality. Although DIC is considered to be associated with serious morbidity and occasional mortality, we did not find any significant differences in the complete remission rate, overall or disease-free survival between DIC+ and DIC- groups. This study is the first to define the clinical characteristics associated with DIC in patients with non-APL AML, but exactly how and when DIC should be treated remains to be determined.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thromb Haemost. 2001 Nov;86(5):1327-30 - PubMed
    1. Leukemia. 1998 Aug;12(8):1182-6 - PubMed
    1. Blood. 1992 Mar 1;79(5):1305-10 - PubMed
    1. Leuk Lymphoma. 2005 Aug;46(8):1169-76 - PubMed
    1. Eur J Haematol. 1995 Aug;55(2):78-82 - PubMed

LinkOut - more resources